NewsRoom Articles - Page 88 of 112 - CanadianCannabisWire

WednesdayOct 10, 2018 12:48 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

TuesdayOct 09, 2018 12:19 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Signs Partnership with Lighthouse Genomics, Inc.

Technology partnership signed with Integral Genomics Inc. (dba Lighthouse Genomics Inc.) to support BLOCKStrain’s registry of genetic profiles of cannabis strains Valuable intellectual property rights of cannabis cultivators under attack from unscrupulous illegal growers, gray market Recent reschedule of first FDA-approved drug derived from cannabis paves the way for sales, underscores necessity of BLOCKStrain’s “Single Source of Trust” registry Legislation efforts growing in U.S. as Canada readies recreational cannabis sales throughout nation Global legal cannabis market projected to reach $146.4 billion by end of 2025 In a move crafted to support advancements in science and technology within the legal cannabis…

ThursdayOct 04, 2018 10:08 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Plans to Grow its Global Patent Application Portfolio to 150-200 within Two Years

LXRP files for tenth patent family, expanding the applicability of its DehydraTECH platform relating to tobacco leaves delivering compounds that may or may not include nicotine LXRP receives three new Australian patents and two new notices of allowance from the U.S.; if all are issued, LXRP would then hold 12 issued patents within its first patent family The company out-licenses its technology that promotes healthier and faster ingestion methods in any country where it already has a patent or is patent-pending Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), which owns the patented DehydraTECH ingestion technology platform, is building its strategic…

ThursdayOct 04, 2018 9:00 am

Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector

CanadianCannabisWire Editorial Coverage: Intangible assets such as patents increasingly dominate the global business landscape, especially in the pharmaceutical sector. Intangible assets are estimated to be worth trillions of dollars in the United States alone. These assets drive deals as companies acquire smaller patent holders. In growing sectors such as cannabis, smaller companies are rushing to establish intangible assets ready for expected market growth. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) is one of the leaders in the world of cannabis, with applications made for more than 50 different patents and more to come. Tilray Inc. (NASDAQ: TLRY) is also…

WednesdayOct 03, 2018 12:36 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Partners with Asterion Cannabis to Develop Organic Cannabinoid Products

PreveCeutical Medical Inc. enters into a joint venture agreement with Asterion Cannabis Inc. to develop several nature-based cannabinoid products; the products will help the company respond to the demands for personalized and effective cannabis therapies The development agreement will see Asterion inject funds at cost, while PreveCeutical will contribute by way of opening its research resources, including personnel for use in the project The percentage ownership of intellectual and product rights from the agreement will be shared between Asterion and PreveCeutical in the ratio of 80 percent to 20 percent Since the agreement involves related parties including current and former…

WednesdayOct 03, 2018 12:07 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Names Seymour to Advisory Board; Updates Spin-Off Transaction

TGOD cited by The Motley Fool for its alternative products, particularly its focus on cannabis-infused beverages and its possible role as a partner for a brand name producer The company also named high profile American investor and TV personality Tim Seymour to its advisory board; it says Seymour will offer advice on global finance strategies TGOD updated its transaction regarding the spinoff of its wholly owned subsidiary, TGOD Acquisition Corporation (“SpinCo”), and announced a private placement of up to $10 million The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) has attained a higher profile by adding well known…

TuesdayOct 02, 2018 10:19 am

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Launch of Certified Organic Cannabis Brand

The Green Organic Dutchman launched its premier organic cannabis brand on September 12 Studies show that Canadian consumers prefer organic cannabis TGOD’s goal is to become the largest organic cannabis brand in the world Partnership with Aurora Cannabis has resulted in a nearly fivefold return on Aurora’s initial investment thus far Coinciding with Canadian Organic Week, Canada’s biggest annual celebration of organic food, farming and products, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) announced the launch of its premium, certified organic cannabis brand on September 12. This marks a significant step toward TGOD’s goal of becoming the…

MondayOct 01, 2018 1:05 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Changing the Efficiency and Future of Drug Delivery

Focused on discovering new technologies that deliver cannabinoids and other beneficial molecules to the bloodstream Bypassing the negative side effects of lighting up Crossing blood brain barrier Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is focused on discovering new technologies that deliver cannabinoids and other lipophilic (fat soluble) beneficial molecules to the bloodstream through efficient and healthy ingestion. The first step to discovering how to deliver a higher percentage into the human bloodstream was to find a way to protect the molecules on their journey through the gastrointestinal system. It was discovered that fats are an excellent conduit, increasing absorption…

FridaySep 28, 2018 11:10 am

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Advancing with ‘Functional’ Cannabis-Infused Beverages

Functional beverage market estimated at $14 billion worldwide currently; CBD hemp extract market expected to hit $22 billion by 2022 Phivida Holdings’ recent announcement of new Oki brand heralds introduction of full spectrum hemp extract-infused iced teas, flavored waters Company also has joint venture with WeedMD Inc. to produce cannabis-infused beverages under Cannabis Beverages, Inc. label The concept that beverages may serve a “functional” purpose has developed within the health and wellness industry as cannabis producers examine ever-expanding options for putting the plant’s properties to use. Hemp-cultivated cannabinoid innovator Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is pursuing the beneficial…

ThursdaySep 27, 2018 10:13 am

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Raise C$20 Million through Unit Sale

A syndicate of underwriters is to purchase 3.8 million units at C$5.27 per unit Sale terms are an amendment of previously announced agreement to sell 1.9 million units Sunniva is closer to achieving full vertical integration in California with launch of Sunniva-branded product lines commencing in Q4 2018 Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically-integrated medical cannabis provider, aims to raise C$20 million through the sale of units of the company to a syndicate of underwriters spearheaded by Beacon Securities Limited and Canaccord Genuity Corp., according to a company press release (http://cnw.fm/ZMw2T). Sunniva announced that the syndicate will purchase 3.8…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977